Garanto , Alex
Dr. Alejandro Garanto 




I started my PhD project in the field of Genetics after finishing my studies in Biology at the University of Barcelona. During my PhD, I focused on elucidating the function of CERKL, an inherited retinal dystrophy gene, as well as the characterization of a knockout mouse model for this gene. After my PhD, I studied the contribution of Ubiquitin and Sumo signalling in the determination of photoreceptor cell fate. Since October 2012, I have been a postdoc in the Blindness Genetic Therapy group at the Department of Human Genetics.  My main research consists in developing new therapeutic approaches for inherited retinal disorders. Currently, together with Dr. Rob Collin, we are investigating a promising antisense oligonucleotide (AON)-based therapy for one of the most recurrent mutations in CEP290 gene, causing Leber congenital amaurosis.


National & International Personal Prizes & Awards

EMBO Short Term Fellowship (2014)

<< go back